Iovate Health Sciences International Inc., commonly known as Iovate, is a leading player in the health and wellness industry, headquartered in Canada. Founded in 1999, the company has established itself as a prominent manufacturer of nutritional supplements, particularly in the sports nutrition and weight management sectors. With a strong presence in North America and expanding operations globally, Iovate is renowned for its innovative products, including protein powders, meal replacements, and dietary supplements. Iovate's commitment to quality and scientific research sets it apart in a competitive market, earning accolades for its flagship brands such as MuscleTech and Six Star Pro Nutrition. The company has achieved significant milestones, including numerous product launches and partnerships, solidifying its position as a trusted name among fitness enthusiasts and health-conscious consumers alike.
How does Iovate Health Sciences International Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Iovate Health Sciences International Inc.'s score of 28 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Iovate Health Sciences International Inc., headquartered in Canada, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Xiwang Foodstuffs Co., Ltd., which may influence its climate-related initiatives and reporting practices. As of now, Iovate has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi). The lack of specific climate pledges or reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the absence of direct emissions data and reduction targets, it is essential for Iovate to consider aligning its practices with industry standards and frameworks to enhance its sustainability profile. This could involve setting measurable targets for emissions reductions and participating in initiatives that promote transparency and accountability in climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Iovate Health Sciences International Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.